Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Mechanism DUSP1 inhibitors(Dual specificity protein phosphatase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bone Marrow Neoplasms | Preclinical | US | 02 Nov 2023 |